| There was an error in our biocides ebulletin dated 16 February 2024. Please see the corrected copy below. Non-approval of an active substance/product type combination not included in the review programme Following the evaluation of the application for approval under the EU BPR, a decision has been taken not to approve the following active substance/product type combination. This will affect NI. Impact on biocidal products and treated articles This active substance was not part of the EU Review Programme which means that there should not be any biocidal products containing it on the NI market at this time. Biocidal products containing this active substance in the relevant product type can only be supplied and used in NI once the active substance is approved and the specific biocidal product is authorised under EU BPR. Phase-out periods for the removal of biocidal products from the NI market are not applicable in these circumstances. Treated articles containing this active substance in the relevant product type cannot be placed on the market in NI at this time. Treated articles containing this active substance in the relevant product type can only be placed on the market in NI once the active substance is approved under the EU BPR. If you are aware of any disproportionate negative impacts that are likely to arise from the non-approval of the active substance/product type combination listed above, please contact us. | 
